Skip to content
Novavax announces phase 2 trial for combined COVID/flu vaccine
Novavax, a biotech company dedicated to developing and commercializing next-generation vaccines for serious ...
Read More
Biotech might beat inflation, offer hope for investors
With an alarming global inflation rate and businesses generating lower revenues, the economic ...
Read More
2-million-year-old DNA could show solutions to future climate challenges
Study the past, if you would define the future, Confucius once said. Staying ...
Read More
Vertex partners with Entrada on new approach for muscle dystrophy treatment
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. have formed a global partnership to ...
Read More
Rolls-Royce introduces new business jet powered by 100% SAF
Rolls-Royce and Gulfstream Aerospace Corp. are conducting the first original equipment manufacturer test ...
Read More
HHS: Alzheimer’s risk linked to systemic racism
Racism and inequities are among the key reasons behind the relatively high rates ...
Read More
EDITORS' CHOICE
Congressional commission urges support in U.S.-China competition for biotech dominance
Maintaining biotechnology superiority is essential to the U.S. economy and national security, and it must be supported with strategic federal funding that leans into America’s ...
Read More
LATEST NEWS
Federal Policy
Nkarta’s Hastings discusses environment for biotech funding in Endpoints panel
Speaking on a recent Endpoints News panel, Nkarta CEO Paul Hastings discussed the impact of regulatory uncertainty and federal funding cuts on the investment climate ...
Federal Policy
U.S. leadership in rare disease drugs at risk, BIO expert tells Orphan Drug Congress
America has long been the global leader in rare disease drug development but this leadership is at risk unless Congress protects key incentives In 1983, ...
Agriculture
BIO applauds reintroduction of two bills aimed at patent reform
The May 1 reintroduction of two bills designed to strengthen the certainty of U.S. patents earned praise from the Biotechnology Innovation Organization (BIO). The Patent ...
Federal Policy
BIO report outlines use of NAMs to reduce animal testing
Safeguarding human health during clinical research is critically important, but biotechnology has shown that this does not always have to mean using animals to test ...
Health
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move into the mid-year, the Biotechnology ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move ...
Read More
International
Bio's View
BIO campaign urges: ‘Invest in America. Vaccinate’
Now that vaccines have all but eliminated smallpox, measles, polio, and other childhood scourges in the U.S., it seems easy ...
Read More
